Paper41004466
Paxlovid plus glucocorticoids treatment in severe Omicron infected patients with hypoxaemia: A prospective multiple-center cohort study.
Wang YJ and 6 others. PLoS One, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Paxlovid plus glucocorticoids treatment in severe Omicron infected patients with hypoxaemia: A prospective multiple-center cohort study. Papers, record 41004466. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41004466
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Paxlovid plus glucocorticoids treatment in severe Omicron infected patients with hypoxaemia: A prospective multiple-center cohort study.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glucocorticoids | Major topic |
| COVID-19 Drug Treatment | Major topic |
| Hypoxia | Major topic |
| Antiviral Agents | Major topic |
| Humans | |
| Male | |
| Female | |
| Middle Aged | |
| Prospective Studies | |
| COVID-19 | |
| Aged | |
| SARS-CoV-2 | |
| Adult | |
| Drug Therapy, Combination | |
| Treatment Outcome | |
| Hospitalization |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32678530 | Dexamethasone in Hospitalized Patients with Covid-19. | N Engl J Med | 2021 | https://conductscience.org/library/papers/32678530 | PubMed |
| 2 | 32958060 | Glucocorticoid therapy does not delay viral clearance in COVID-19 patients. | Crit Care | 2020 | https://conductscience.org/library/papers/32958060 | PubMed |
| 3 | 36767517 | Outcomes of Elderly Patients Hospitalized with the SARS-CoV-2 Omicron B.1.1.529 Variant: A Systematic Review. | Int J Environ Res Public Health | 2023 | https://conductscience.org/library/papers/36767517 | PubMed |
| 4 | 33486496 | Early Use of Corticosteroid May Prolong SARS-CoV-2 Shedding in Non-Intensive Care Unit Patients with COVID-19 Pneumonia: A Multicenter, Single-Blind, Randomized Control Trial. | Respiration | 2021 | https://conductscience.org/library/papers/33486496 | PubMed |
| 5 | 34966985 | Early corticosteroid initiation delays viral RNA clearance in respiratory secretions of COVID-19 patients. | Adv Respir Med | 2021 | https://conductscience.org/library/papers/34966985 | PubMed |
| 6 | 33632000 | A Comparison of Methylprednisolone and Dexamethasone in Intensive Care Patients With COVID-19. | J Intensive Care Med | 2021 | https://conductscience.org/library/papers/33632000 | PubMed |
| 7 | 32876695 | Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial. | JAMA | 2020 | https://conductscience.org/library/papers/32876695 | PubMed |
| 8 | 37757919 | Effect of dexamethasone dose on outcomes in acute COVID-19 disease: A systematic review and meta-analysis. | J Infect | 2023 | https://conductscience.org/library/papers/37757919 | PubMed |
| 9 | 36001529 | Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge. | N Engl J Med | 2022 | https://conductscience.org/library/papers/36001529 | PubMed |
| 10 | 36777445 | Efficacy and safety of Paxlovid in severe adult patients with SARS-Cov-2 infection: a multicenter randomized controlled study. | Lancet Reg Health West Pac | 2023 | https://conductscience.org/library/papers/36777445 | PubMed |
| 11 | 35653428 | Effectiveness of Paxlovid in Reducing Severe Coronavirus Disease 2019 and Mortality in High-Risk Patients. | Clin Infect Dis | 2023 | https://conductscience.org/library/papers/35653428 | PubMed |
| 12 | 34649502 | Association between glucocorticoids treatment and viral clearance delay in patients with COVID-19: a systematic review and meta-analysis. | BMC Infect Dis | 2021 | https://conductscience.org/library/papers/34649502 | PubMed |
| 13 | 32499448 | Comparison of clinical characteristics and outcomes of patients with coronavirus disease 2019 at different ages. | Aging (Albany NY) | 2020 | https://conductscience.org/library/papers/32499448 | PubMed |
| 14 | 35172054 | Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19. | N Engl J Med | 2022 | https://conductscience.org/library/papers/35172054 | PubMed |
| 15 | 33317589 | Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes. | Crit Care | 2020 | https://conductscience.org/library/papers/33317589 | PubMed |
| 16 | 36905638 | Treatment effect modifiers in hospitalised patients with COVID-19 receiving remdesivir and dexamethasone. | Infect Dis (Lond) | 2023 | https://conductscience.org/library/papers/36905638 | PubMed |
| 17 | 37515802 | Dexamethasone, dexamethasone + remdesivir in treating moderate to severe COVID-19: retrospective observational cohort study. | J Infect Dev Ctries | 2023 | https://conductscience.org/library/papers/37515802 | PubMed |
| 18 | 33032534 | Clinical characteristics and manifestations in older patients with COVID-19. | BMC Geriatr | 2020 | https://conductscience.org/library/papers/33032534 | PubMed |
| 19 | 33631065 | Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. | N Engl J Med | 2021 | https://conductscience.org/library/papers/33631065 | PubMed |
| 20 | 35084022 | Remdesivir Plus Dexamethasone Versus Dexamethasone Alone for the Treatment of Coronavirus Disease 2019 (COVID-19) Patients Requiring Supplemental O2 Therapy: A Prospective Controlled Nonrandomized Study. | Clin Infect Dis | 2022 | https://conductscience.org/library/papers/35084022 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42282861 | Corticosteroids with or without antiviral therapy in elderly patients hospitalized with COVID-19 during the Omicron era: A multicenter real-world study. | J Virus Erad | 2026 | https://conductscience.org/library/papers/42282861 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41004466
GET https://conductscience.org/api/papers/v1/41004466/references?page=2